Cargando…

Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer

The aim of the present study was to identify the appropriate DNA sequence and design high-quality primers for methylation-specific polymerase chain reaction (MSP). These primers may be used to examine and identify patients with early-stage epithelial ovarian carcinoma (EOC). Opioid binding protein/c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bi, Yu, Lei, Luo, Xin, Huang, Lin, Li, Qin-Shan, Shao, Xiao-Shan, Liu, Yi, Fan, Yu, Yang, Guo-Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494804/ https://www.ncbi.nlm.nih.gov/pubmed/28693156 http://dx.doi.org/10.3892/ol.2017.6111

Ejemplares similares

OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis
por: Shao, Yang, et al.
Publicado: (2021)

OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
por: Cui, Yan, et al.
Publicado: (2008)

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
por: Gabra, H
Publicado: (2012)

OPCML is hypermethylated in a subset of patients with metaplastic changes in their esophagus
por: Castaño-Rodríguez, Natalia, et al.
Publicado: (2018)

Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases
por: Wasenang, Wiphawan, et al.
Publicado: (2019)

Inactivating mutations and X-ray crystal structure of the tumor suppressor OPCML reveal cancer-associated functions
por: Birtley, James R., et al.
Publicado: (2019)

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
por: Xing, Xiangbin, et al.
Publicado: (2017)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
por: Yang, Jiani, et al.
Publicado: (2021)

Early stage epithelial ovarian cancer metastasis through peritoneal fluid circulation
por: Purbadi, Sigit, et al.
Publicado: (2021)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients
por: Hendriks, Rianne J., et al.
Publicado: (2018)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer
por: Zhou, Juan, et al.
Publicado: (2018)

Laparoscopic and Laparotomic Restaging in Patients With Apparent Stage I Epithelial Ovarian Cancer: A Comparison of Surgical and Oncological Outcomes
por: Wang, Yongxue, et al.
Publicado: (2022)

Circulating cell-free DNA-based methylation patterns for breast cancer diagnosis
por: Zhang, Xianyu, et al.
Publicado: (2021)

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

Epithelial–mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
por: Li, Y-M, et al.
Publicado: (2013)

Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma
por: Hsieh, Shu-Feng, et al.
Publicado: (2019)

Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer
por: Park, Yu Ran, et al.
Publicado: (2018)

Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
por: Fu, Bo, et al.
Publicado: (2018)

Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Zhou, Quan, et al.
Publicado: (2016)

Circulating Vitamin D and Risk of Epithelial Ovarian Cancer
por: Arslan, Alan A., et al.
Publicado: (2009)

Advances in circulating microRNAs as diagnostic and prognostic markers for ovarian cancer
por: Zheng, Hong, et al.
Publicado: (2013)

Accurate detection of early-stage lung cancer using a panel of circulating cell-free DNA methylation biomarkers
por: Hu, Shuo, et al.
Publicado: (2023)

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers
por: Punia, Sohan, et al.
Publicado: (2021)

Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature
por: Guo, Xiaoyue M., et al.
Publicado: (2021)

BubR1 as a prognostic marker for recurrence-free survival rates in epithelial ovarian cancers
por: Lee, Y-K, et al.
Publicado: (2009)

The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma
por: Li, Long, et al.
Publicado: (2022)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
por: Sun, Li-Yue, et al.
Publicado: (2021)

Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
por: Smith, Haller J., et al.
Publicado: (2017)

Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
por: Rahat, Beenish, et al.
Publicado: (2020)

Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer
por: Li, Yuan, et al.
Publicado: (2019)

Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy
por: Yousefi, Meysam, et al.
Publicado: (2021)

Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer
por: Fitriawan, Akbar Satria, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum—Implications for the Choice of Circulating Tumour DNA Methylation Markers
por: Le, Anh Viet-Phuong, et al.
Publicado: (2018)

Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors
por: Moon, Min Hoan, et al.
Publicado: (2023)

Global Analysis of DNA Methylation by Methyl-Capture Sequencing Reveals Epigenetic Control of Cisplatin Resistance in Ovarian Cancer Cell
por: Yu, Wei, et al.
Publicado: (2011)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_64gc7mkbvn29avt3obkitna8db